Oncolytics Biotech Inc (ONCY)
1.04
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
1.03
-0.01
(-0.96%)
After-Hours: 20:00
Oncolytics Biotech Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | -4.613M |
| September 30, 2022 | -3.038M |
| June 30, 2022 | -5.381M |
| March 31, 2022 | -4.962M |
| December 31, 2021 | -5.172M |
| September 30, 2021 | -2.875M |
| June 30, 2021 | -5.680M |
| March 31, 2021 | -4.393M |
| December 31, 2020 | -4.212M |
| September 30, 2020 | -4.903M |
| June 30, 2020 | -4.420M |
| March 31, 2020 | -2.958M |
| December 31, 2019 | -5.423M |
| September 30, 2019 | -3.498M |
| June 30, 2019 | -3.538M |
| March 31, 2019 | -2.548M |
| December 31, 2018 | -3.432M |
| September 30, 2018 | -2.672M |
| June 30, 2018 | 0.506M |
| March 31, 2018 | -3.683M |
| December 31, 2017 | -2.188M |
| September 30, 2017 | -3.006M |
| June 30, 2017 | -3.394M |
| March 31, 2017 | -2.984M |
| December 31, 2016 | -2.785M |
| Date | Value |
|---|---|
| September 30, 2016 | -2.269M |
| June 30, 2016 | -2.183M |
| March 31, 2016 | -2.203M |
| December 31, 2015 | -3.633M |
| September 30, 2015 | -1.811M |
| June 30, 2015 | -4.192M |
| March 31, 2015 | -2.228M |
| December 31, 2014 | -2.816M |
| September 30, 2014 | -4.182M |
| June 30, 2014 | -5.358M |
| March 31, 2014 | -5.606M |
| December 31, 2013 | -4.460M |
| September 30, 2013 | -6.164M |
| June 30, 2013 | -4.997M |
| March 31, 2013 | -8.362M |
| December 31, 2012 | -6.632M |
| September 30, 2012 | -8.156M |
| June 30, 2012 | -11.09M |
| March 31, 2012 | -8.518M |
| December 31, 2011 | -7.271M |
| September 30, 2011 | -6.677M |
| June 30, 2011 | -5.184M |
| March 31, 2011 | -3.925M |
| December 31, 2010 | -3.681M |
| September 30, 2010 | -4.741M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.680M
Minimum
Jun 2021
-2.875M
Maximum
Sep 2021
-4.338M
Average
-4.420M
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
| Acasti Pharma Inc | -1.892M |
| Aurinia Pharmaceuticals Inc | 14.25M |
| Edesa Biotech Inc | -1.406M |
| Lexaria Bioscience Corp | -0.6766M |
| Xenon Pharmaceuticals Inc | -35.54M |